Prestige V + WNV with Havlogen (Canada)

This page contains information on Prestige V + WNV with Havlogen for veterinary use.
The information provided typically includes the following:
  • Prestige V + WNV with Havlogen Indications
  • Warnings and cautions for Prestige V + WNV with Havlogen
  • Direction and dosage information for Prestige V + WNV with Havlogen

Prestige V + WNV with Havlogen

This treatment applies to the following species:
Manufacturer: Merck Animal Health

Equine Vaccine

ENCEPHALOMYELITIS - RHINOPNEUMONITIS - INFLUENZA - WEST NILE VIRUS VACCINE, EASTERN & WESTERN, KILLED VIRUS, KILLED FLAVIVIRUS CHIMERA, TETANUS TOXOID

A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesviruses types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains (EIV A/Equine 2/Kentucky/93 American, EIV A/Equine 2/Kentucky/02 American, EIV A/Equine 2/Newmarket/2/93 Eurasian), West Nile virus - flavivirus chimera and tetanus toxoid.

Prestige V + WNV with Havlogen Indications

For vaccination of healthy horses 6 months of age or older; as an aid in the prevention of disease caused by Eastern and Western encephalomyelitis viruses and tetanus; as an aid in the control of respiratory disease caused by EIV, EHV-1 and EHV-4; as an aid in reduction of virus shedding of EIV, EHV-1 and EHV-4; and as an aid in reduction of disease, encephalitis, and viremia caused by West Nile virus. Duration of immunity (DOI) has been shown to be at least 6 months for EIV. DOI for the West Nile virus fraction is under development. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

DOSE: For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 - 4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

CAUTIONS: Store at 2°-7°C (35°-45°F). Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Inject deep into the muscle only. Local reactions may occur at the injection sites in vaccinates, and most of these reactions resolve in 3 to 7 days following vaccination. If allergic reaction occurs, treat with epinephrine.

WARNING: Needle is sharp and may cause injury to self or animals if not handled properly or disposed of properly. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. Contact a physician immediately if an accidental injection occurs.

ANTIBIOTICS: Product contains neomycin, polymyxin B, nystatin and gentamicin.

PRESERVATIVE: Thimerosal is added as a preservative.

Adjuvant: Intervet’s Proprietary Technology

FOR USE IN ANIMALS ONLY

Intervet Inc., Omaha, NE 68103, USA

1 888 306-0069 (CAN)

US Veterinary License No. 165A

10-0135INS

 

 

 

10 Doses

10 x 1 mL Syringes with Separate Sterile Needles

10-0206PFC, 10-0206PCH

10 Doses

10 mL

10-0135PFC

NAC No.: 12082530

MERCK ANIMAL HEALTH
Intervet Canada Corp.

16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7
Order Desk:   514-428-7013
Toll-Free:   866-683-7838
Fax:   Toll-free 888-498-4444; local 514-428-7014
Website:   www.merck-animal-health.ca
Every effort has been made to ensure the accuracy of the Prestige V + WNV with Havlogen information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web1)